3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
5
Colorectal Neoplasms
3
Thyroid Neoplasms
2
Ovarian Neoplasms
2
Glioma
2
Endometrial Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neurofibromatosis 1
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Hereditary Sensory and Autonomic Neuropathies
1
Hematologic Neoplasms
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Brain Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Rituximab
4
Cladribine
2
tovorafenib
1
polatuzumab vedotin
1
obinutuzumab
1
immunotoxin HA22
1
ibrutinib
1
Vemurafenib
1
Specimen Handling
1
Prednisone
1
Lenalidomide
1
Famotidine
1
Doxorubicin
1
Diphenhydramine
1
Dexamethasone
1
Cyclophosphamide
1
Calcium Dobesilate
1
CT-P10
1
Biopsy
1
Aspirin
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Hairy Cell
×
binimetinib
×
30 days
×
Clear all
No trials found.